Blue Whale Update: New Energy Stock

Stephen Yiu - Blue Whale Fund Manager

 

Stephen Yiu is the Chief Investment Officer at Blue Whale Capital and Lead Manager of the Blue Whale Growth Fund.

Stephen co-founded Blue Whale Capital with Peter Hargreaves, co-founder of Hargreaves Lansdown, in 2016. The Blue Whale Growth Fund was launched in September 2020 and is a long-only global equity fund focusing on developed markets.

Stephen adopts a high conviction, active approach based on
bottom-up, fundamental research.

Whilst we tend not to discuss investee companies outside of the Top 10, many people have noticed a new sector appearing on our Factsheet in the last few months – Energy. We have so far made one investment into the energy sector, in a company called Canadian Natural Resources.

As always, when we invest in a company, we look for both the highest levels of quality and structural growth drivers that should assist in our mission to deliver outperformance over the long term. We consider that Canadian Natural Resources delivers on both in abundance.

The company itself owns some of the highest quality oil assets in the world – the crown jewel of which are its oil sands mines in Alberta, Canada. What makes these mines so important is that their reserves are predicted to last approximately 45 years – extremely favourable when compared to the average US shale company reserves of around 10 years. In addition, there is “zero decline” meaning minimal capital expenditure and no new costly exploration required to maintain production levels. Again, this compares favourably to conventional oil assets with around 10% per annum decline and as much as 40% per annum for US shale oil. The low cost of production means that the breakeven point for Canadian Natural is just $30 per barrel (the price today is around $75 per barrel). All this, combined with a strong management team and track record of 23 consecutive years of dividend increases, gives us the quality we are looking for in this previously unloved sector.

Whilst it is a company which has been on our radar for a while, the issue with Canadian Natural Resources (and thus keeping it out of the portfolio) had been the sector in which it sits. But the energy sector itself is now far more appealing. The biggest driver of its renewed appeal for investors are the indicators of supply challenges from the three largest oil producers – the US, Saudi Arabia and Russia.

In the US, the shale revolution in early 2010 was one of the most significant breakthroughs in the 100-year history of the oil industry. We believe it is unlikely to be repeated, whilst economics and growth profiles are deteriorating as high decline rates, cost inflation, and depletion of the best wells all begin to bite.

In Saudi Arabia and indeed OPEC as a whole, we believe the record of consistently missing production quotas demonstrates their “spare capacity” is close to being exhausted. Coupled with worsening US relations, this is likely to bias OPEC towards limited supply growth.

Clearly, for Russia, geopolitics are worsening. The withdrawal of Western technology and oil field services firms from Russia will weigh heavy on supply, whilst Western nations taking a stance against the war in Ukraine is leaving the Russian oil industry painfully lacking investment.

Finally, a general lack of investment globally with total industry capex slashed by around 50% over the last 8-10 years has put pressure on the sector. Another telling stat is that enrolment numbers in petroleum engineering courses in the US are also down approximately 50% over the same period.

Whilst we do not attempt to forecast the oil price, all the above leads us to believe the price is well supported at these higher levels.

With the key oil-producing nations suffering for one reason or another, Canada has an ace up its sleeve in the form of its ESG (environmental, social and governance) credentials. Among the top oil exporting nations, Canada offers the highest aggregate ESG score, whilst Canadian Natural Resources itself employs several initiatives and measures in recognition of its ESG responsibilities – ranging from reduction in fresh water usage and land reclamation, to workplace safety and inclusion. Whilst the discussion of ESG may seem laughable when discussing producers of fossil fuels, a more socially and environmentally-aware end consumer will be more comfortable in their consumption of natural resources if the company can demonstrate initiatives to limit its impact on the environment and improve its social credentials.

Canadian Natural Resources, therefore, sits well in our portfolio of high quality businesses, broadening out our portfolio exposure into a sector which we believe will take a greater share of the global GDP over the medium to long term.

.

Blue Whale Growth Fund is manufactured by Blue Whale Capital LLP and represented in Malta by MeDirect Bank (Malta) plc.

 


Blue Whale Key Risks & Disclaimers:

The Blue Whale Growth Fund was launched in September 2020. All references to actions before this date relate to the LF Blue Whale Growth Fund.  Information on the LF Blue Whale Growth Fund is provided for comparison purposes only; it is a UK UCITS which is not registered for sale in nor is it promoted to investors in the EEA.  Whilst the investment objectives and charges are not identical, both funds are run on the same investment process.

Please note that the information provided in this article is not to be construed as advice and any views we express on holdings do not constitute investment recommendations and must not be viewed as such. If you are unsure as to the suitability of an investment for your circumstances, please seek independent financial advice. Investments can go down in value as well as up so you may get back less than you invested. Your capital is at risk. Past performance is not a guide to future performance.Blue Whale Capital LLP is authorised and regulated by the UK Financial Conduct Authority.

There are significant risks associated with investment in the Fund referred to herein. Investment in the Fund is intended for investors who understand and can accept the risks associated with such an investment including potentially a substantial or complete loss of their investment.

Past performance is not a guide to future performance. The value of investments and any income derived from them can go down as well as up and the value of your investment may be volatile and be subject to sudden and substantial falls.

Investment in a Fund with exposure to emerging markets involves risk factors and special considerations which may not be typically associated with investing in more developed markets. Political or economic change and instability may be more likely to occur and have a greater effect on the economies and markets of emerging countries. Adverse government policies, taxation, restrictions on foreign investment and on currency convertibility and repatriation, currency fluctuations and other developments in the laws and regulations of emerging countries in which investment may be made, including expropriation, nationalisation or other confiscation could result in loss to the Fund.

Income from investments may fluctuate. Changes in rates of exchange may have an adverse effect on the value, price or income of investments. Fund charges may be applied in whole or part to capital, which may result in capital erosion. The Authorised Corporate Director may apply a dilution adjustment as detailed in the Prospectus. The Fund is not traded on an exchange or recognised market.

The foregoing list of risk factors is not complete, and reference should be made to the Fund’s Prospectus and KID.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from Blue Whale Growth Fund. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Notes from the Trading Desk – Franklin Templeton

Franklin Templeton’s Notes from the Trading Desk offers a weekly overview of what our professional traders and analysts are watching in the markets. As part of Templeton Global Equity Group, the European equity desk is manned by a team of professionals based in Edinburgh, Scotland, whose job it is to monitor the markets around the world. Their views are theirs alone and are not intended to be construed as investment advice.

The Digest

Global equities were broadly higher again last week, continuing their strong start to the new year. The MSCI World Index closed the week up 3.2%, while regionally, the S&P 500 Index closed the week up 2.7%, the STOXX Europe 600 Index was up 1.8%, and the MSCI Asia Pacific Index closed up a notable 4.6%. The US December Consumer Price Index (CPI) print on Thursday was the focus for most of the week, with equity markets grinding higher into the release of the data and maintaining their strength on Friday. It was in line with market expectations, with a -0.1% headline reading and +0.3% core (excluding food and energy). Outside of the CPI data, the new corporate earnings season is coming into focus and so far, reports are not as bad as feared.

Meanwhile, gas prices in the European Union (EU) dropped 6.8% last week, which helps overall sentiment. Despite the equity market rally, in the latest Bank of America Merrill Lynch “Flow Show” report revealed that European equity funds lost another US$500 million last week, their 48th consecutive weekly outflow, with US equity funds shedding US$2.6 billion.

Don’t fight the Fed Market?

There is still a lot of head-scratching going on with regards to market moves so far this year. Hedge funds have driven stocks higher at the start of the year and markets seem resilient, but short covering seems to be a significant factor.

There is still a lot of push and pull. No part of the market is now technically oversold, whilst the move in the CBOE VIX to below 20 was taken as a strong sell signal in 2022. The VIX hit 18.01 on Friday, a new 12-month low, whilst the European equivalent, the V2X, also hit a new 12-month low. The STOXX Europe 600 Index is trading nearly 6% above its 200-day moving average (a key technical level) and stocks were higher again vs. real yields (inverted) last week. Nevertheless, European stocks are still trading at a large valuation discount to US stocks, despite the performance in the fourth quarter of 2022.

The new market consensus for Federal Reserve (Fed) rate hikes is for 50 basis points (bps) to be added in the first half of 2023, followed by 200 bps of cuts over the following 18 months. The market expects a terminal rate of 4.9% in June 2023, which is not in line with what Fed officials have been saying. Last week, Atlanta Fed Bank President Raphael Bostic (a non-voter) reiterated that he favours getting the benchmark rate to between 5%-5.25% before reassessing what is required. San Francisco Fed Bank President Mary Daly (also a non-voter), said she expects the Federal Open Market Committee (FOMC) to raise rates above 5%, but doesn’t know yet what that terminal rate will be. Philadelphia Fed Bank President Patrick Harker (a voter) suggested there would be a series of rate hikes still to come, but that 25 bps hikes were more appropriate going forward. The market is fully pricing in a 25-bps hike at the start of February. Given the terminal rate expectations, we can infer that the market is expecting the Fed to make a dovish pivot in the next few months.

European Central Bank (ECB) and Bank of England (BoE) officials continue to hint at a further tightening in rates. ECB policymaker Robert Holzmann, a known hawk, said only a slowdown in core inflation can alter the ECB’s plans for raising interest rates. Isabel Schnabel, a member of the ECB Executive Board, was equally hawkish when she said that interest rates must still rise significantly, even as consumer price rises dipped back into the single digits for the first time since August 2022. This morning another member, Olli Rehn, said that he sees “significant rate hikes” at the next meetings.

Finally, Catherine Mann, member of the BoE’s Monetary Policy Committee and another known hawk, warned that the United Kingdom may need a “significant recession” if the central bank is to reach its 2% target.

It remains to be seen whether the market will eventually give in and follow the hawkish central bank tones, or whether the central banks will pivot to a more dovish stance than they have adopted until now. The market continues to take the commentary in stride, but many are still cautious (there still seems to be more bears than bulls in the market).

Gas prices were clearly a big driver of inflation through 2022, but they have now fallen 21% this year, and are now down 82% from their August peak. The upcoming earnings season will be very interesting and could set the tone for the first half of 2023. We would note that the  earnings forecasts for the STOXX Europe 600 Index have dropped fairly notably over the last few months.

Week in review

Europe

Last week was another positive one for European stocks, with the STOXX 600 Index closing up 1.8% and on track for its best January since 2015. Thursday’s US CPI print was the focus for most of the week. It seemed initially like the market didn’t really know how to react to it, with Thursday afternoon becoming fairly choppy. Outside of that, there were very few market catalysts through the week, meaning stocks continued the same course as the prior week. Thus, the rotation into last year’s losers continued, with cyclicals recovering ground vs. defensives. A basket of stocks consisting of the STOXX 600 Index’s 20 worst performers of 2022 is now up 20% year-to-date. Europe’s largest company, LVMH, also hit a new all-time high. More generally, European equities continue to outperform US equities, as they have done since November.

The German DAX Index continues to perform well, up 3.3% last week, as China reopening hopes helped sentiment. Meanwhile, the UK FTSE 100 Index continues to underperform so far this year, but was an outperformer last year, locking in a gain of nearly 1% in 2022 given its defensive nature and oil weighting.

Tech stocks continue to get a little respite, with the sector up last week, along with real estate stocks, amidst a pullback in interest rates. Travel and leisure and retail stocks were also higher last week. Health care was the only sector to finish the week lower in Europe,  given the risk-on move as investors rotate into more cyclical stocks. So far this year, it appears that luxury stocks are doing especially well, along with EU high leverage and tech.

In terms of macro data, the eurozone unemployment rate remained unchanged in November at a record low of 6.5%. Germany’s November industrial production reading came in slightly higher than expected at 0.2%. UK retailers enjoyed their best Christmas season since the start of the pandemic, with footfall rising 15% in December vs. a year before. Also, importantly in terms of growth, the UK monthly gross domestic product (GDP) unexpectedly grew 0.1% in November.

United States

Last week was another positive week for US equities, as the S&P 500 Index has seen its best start to the year since 2003, gaining 2.7% last week and 4.2% year-to-date. The picture was good across US markets, with the Nasdaq 100 Index up 4.5% and the Russell 2000 index 5.3% last week. The Nasdaq posted a sixth straight gain on Friday, which is its longest winning streak since November 2021.

With hopes rising that inflation has peaked and the Fed will pivot from its hawkish stance, stocks which suffered last year outperformed last week. The US 10-year Treasury yield slipped back to 3.5% as rate- hike expectations continue to fall; some Fed officials are guiding for a 25-bps hike in February, rather than 50 bps.

Looking at the S&P 500 Index chart, after bouncing off the 3800 level early in the month it has now pushed through its 200-day moving average and is testing resistance at 4000. This will be an important level for market technicians to keep an eye on this week.

In terms of sectors, consumer discretionary names outperformed last week, along with tech stocks. Defensives lagged in a “risk-on” environment, with consumer staples and pharmaceutical stocks both lower.

Fourth-quarter earnings season kicked off on Friday with a number of US banks reporting earnings. It was a largely positive outcome with financials stocks gaining ground.

As discussed, macro data was a key talking point with US CPI in line with expectations but markedly lower month-over-month and year-over-year. In addition, a University of Michigan report showed a fall in inflation expectations.

Whilst the BAML Bull & Bear Indicator remained in bearish territory last week, the CNN Fear and Greed Index swung firmly into “Greed” territory in recent weeks. This suggests to us that US investor sentiment has improved sharply in 2023 given the hopes of falling inflation, potential easing of central bank tightening and improved chances of a soft landing.

Asia

Last week, all major Asian markets closed higher, with the MSCI APAC Index up 4.59%. The main macro catalyst was the US December CPI number.

Hong Kong’s equity market closed up3.56%, logging a third straight week of gains, as cooling US inflation fuelled risk appetite. Macau casino operators rallied, as Macau saw a surge in travellers after reopening. Autos gained on a slew of positive news: Beijing announced it will loosen car-plate restrictions for auto buyers and remove travel restrictions for electric vehicles; the China Association of Automobile Manufacturers (CAAM) said it sees the EV market share continuing to increase due to supporting policies; and BYD announced its expansion into the India market.

The oil sector advanced after China National Offshore Oil Corporation (CNOOC) lifted capex expenditure for 2023 to raise energy supply, as Beijing looks to raise production to safeguard energy security and fuel a rebound in economic growth.

Meanwhile, Japan’s equity market closed the week up a relatively subdued 0.56%, with investors perhaps more focused on the forthcoming Bank of Japan (BoJ) meeting on Tuesday/Wednesday of this week.

As core CPI in the Tokyo area rose 4% year-over-year in December—the fastest rate in 40 years—speculation grew that the BoJ could revise up its inflation forecasts and look at further monetary policy adjustments. The central bank surprisingly tweaked its yield curve control (YCC) framework in December. As a result, the BoJ was again forced to conduct unscheduled bond buying operations to keep the 10-year JGB yield around its new 0.50% cap, roughly the level at which it ended the week. While the revisions to the BoJ’s inflation forecasts are widely expected, further monetary policy changes may not be imminent until after the end of Governor Kuroda’s term in April.

Of 43 economists surveyed by the Bloomberg news agency, all but one predicted that the BoJ would leave its policy unchanged in January. Looking ahead, more than half of respondents saw a move towards policy normalisation by July.

Asked whether the BoJ needs to tweak its ultra-loose policy, PM Kishida said that monetary policymakers must have a view on the outlook for the economy, and there needs to be careful communication and dialogue with markets.

Looking at sectors, steel stocks were the best performers last week, followed by banks and mining. Agriculture, real estate and utilities were underperformers.

The Japanese yen strengthened against the US dollar last week.

China’s mainland equity market performed solidly last week,  up 1.19%. Again, the softer US CPI print helped, but earlier in the week, China issued a large quota for crude oil imports to prepare for an expected uptick in energy demand as infections start to wane and economic activity returns to normal.

The market anticipates more easing from Beijing shortly, e.g., RRR cut, LPR cut, property boost, etc., as Beijing is committed to revive the economy in 2023. Note: GDP growth targets will be announced at the National People’s Congress in March.

On the trade front, China’s exports fell 9.9% in December from a year ago, as global demand softened and rising infections disrupted activity after the government rolled back pandemic restrictions. Imports fell 7.5%. For the full year, China’s trade surplus reached an all-time high of $US878 billion, as strong export growth for most of 2022, and the rising price of goods boosted the value of exports.

In other economic news, China’s inflation rose 1.8% in December. Core inflation, which excludes food and energy prices, picked up slightly after remaining unchanged for three consecutive months.

Week ahead

Holidays: Monday 16 January: United States

Macro week ahead highlights

Europe may be starting the new year on a more optimistic note. We think data will likely confirm headline inflation has passed the peak in the euro area and the United Kingdom. Meanwhile, the German ZEW survey may indicate some of the gloom is dissipating as a warmer-than-normal winter eases the risk of a severe energy crunch.

  • Still, central banks will remain vigilant as underlying price pressures remain elevated. Minutes from the ECB’s meeting in December may provide clues about the size of future rate hikes.
  • The BoE will also closely monitor labour market data as the committee weighs whether recent signs that the labour market is cooling are enough to warrant a slower pace of hiking.

Euro-area key events

Tuesday 17 January:  UK Unemployment Rate; Germany ZEW Expectations Survey

Wednesday 18 January: UK CPI Inflation; Euro-area Final CPI Inflation

Thursday 19 January: ECB Monetary Policy Account

Friday 20 January UK Retail Sales

Global events calendar:

Monday 16 January

  • The World Economic Forum’s (WEF’s) annual meeting commences in Davos through Friday. This will be the first winter gathering of global leaders since before the pandemic. The WEF’s annual Global Risks Report showed the outlook for the next two years will be dominated by the threat of recession, the cost-of-living crisis and mounting debt distress.
  • January Eurozone Economic Survey
  • January Germany Economic Survey
  • January France Economic Survey
  • France Budget Balance year-to-date
  • January Spain Economic Survey
  • Italy General Government Debt
  • US Martin Luther King, Jr. holiday (market closed)

Tuesday 17 January

  • UK Labour Market Statistics
  • Germany ZEW Survey; Germany CPI
  • UK Claimant Count & ILO Unemployment Rate
  • Italy CPI
  • US Empire State manufacturing survey
  • BoJ meeting

Wednesday 18 January

  • UK CPI Inflation
  • Euro area Final CPI Inflation
  • Eurozone EU27 New Car Registrations
  • Italy Trade Balance Total
  • UK House Price Index
  • US Core PPI; US Manufacturing & Industrial production; US Business inventories

Thursday 19 January

  • ECB Monetary Policy Account
  • Switzerland Producer & Import Prices
  • Spain Trade Balance
  • UK Bank of England Bank Liabilities/Credit Conditions surveys
  • Italy Current Account Balance
  • US housing starts & building permits

Friday 20 January

  • UK Retail Sales
  • Germany Producer Price Index (PPI)
  • Spain house transactions
  • US existing home sales

 


Franklin Templeton Key risks & Disclaimers:

What Are the Risks?

All investments involve risks, including the possible loss of principal. The value of investments can go down as well as up, and investors may not get back the full amount invested.  Stock prices fluctuate, sometimes rapidly and dramatically, due to factors affecting individual companies, particular industries or sectors, or general market conditions. Bond prices generally move in the opposite direction of interest rates. Thus, as prices of bonds in an investment portfolio adjust to a rise in interest rates, the value of the portfolio may decline. Investments in foreign securities involve special risks including currency fluctuations, economic instability and political developments. Investments in developing markets involve heightened risks related to the same factors, in addition to those associated with their relatively small size and lesser liquidity.

Any companies and/or case studies referenced herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. The information provided is not a recommendation or individual investment advice for any particular security, strategy, or investment product and is not an indication of the trading intent of any Franklin Templeton managed portfolio.

Past performance is not an indicator or guarantee of future performance. There is no assurance that any estimate, forecast or projection will be realised.

This article reflects the analysis and opinions of Franklin Templeton’s European Trading Desk as of 16th January 2023, and may vary from the analysis and opinions of other investment teams, platforms, portfolio managers or strategies at Franklin Templeton. Because market and economic conditions are often subject to rapid change, the analysis and opinions provided may change without notice. An assessment of a particular country, market, region, security, investment or strategy is not intended as an investment recommendation, nor does it constitute investment advice. Statements of fact are from sources considered reliable, but no representation or warranty is made as to their completeness or accuracy. This article does not provide a complete analysis of every material fact regarding any country, region, market, industry or security. Nothing in this document may be relied upon as investment advice or an investment recommendation. The companies named herein are used solely for illustrative purposes; any investment may or may not be currently held by any portfolio advised by Franklin Templeton. Data from third-party sources may have been used in the preparation of this material and Franklin Templeton (“FT”) has not independently verified, validated or audited such data. FT accepts no liability whatsoever for any loss arising from use of this information and reliance upon the comments, opinions and analyses in the material is at the sole discretion of the user. Products, services and information may not be available in all jurisdictions and are offered by FT affiliates and/or their distributors as local laws and regulations permit. Please consult your own professional adviser for further information on availability of products and services in your jurisdiction.

Issued by Franklin Templeton Investment Management Limited (FTIML) Registered office: Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority.

 

MeDirect Disclaimers:

This information has been accurately reproduced, as received from Franklin Templeton Investment Management Limited (FTIML). No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.